Chinese Journal of Organic Chemistry >
Synthesis and Antibacterial Activity of 5-(2-Hydroxyphenyl)-1,3,4- thiadiazol-2-yl-sulfanyl Acetyl Hydrazones
Received date: 2012-06-12
Revised date: 2012-10-08
Online published: 2012-10-12
Supported by
Project supported by the Application of Basic Project of the Science and Technology Agency of Sichuan Province (No. 2010JY0148) and the Key Projects of the Science and the Technology Bureau of Leshan City in Sichuan Province (No. 08SZD092).
A series of 5-(2-hydroxyphenyl)-1,3,4-thiadiazol-2-yl-sulfanyl acetyl hydrazones were synthesized with 2-mercapto-5-(2-hydroxyphenyl)-1,3,4-thiadiazole as starting material, followed by thioetherification, hydrazide reaction and hydrazone reaction. The structures of these compounds were characterized by 1H NMR, 13C NMR, IR, MS techniques and elemental analysis. The antimicrobial activities of these compounds were also originally studied. The results showed that most of these compounds have potent antibacterial activities. These compounds of aromatic aldehyde-5-(2-hydroxyphen-yl)-1,3,4- thiadiazol-2-yl-sulfanyl acetyl hydrazone (4a~4h) showed better antibacterial activities than 2-butenal-5-(2-hydroxyphenyl)-1,3,4-thiadiazol-2-yl-sulfanyl acetyl hydrazone (4i).
Wang Yinghong , Yang Lu , Liu Zhichang . Synthesis and Antibacterial Activity of 5-(2-Hydroxyphenyl)-1,3,4- thiadiazol-2-yl-sulfanyl Acetyl Hydrazones[J]. Chinese Journal of Organic Chemistry, 2013 , 33(01) : 154 -158 . DOI: 10.6023/cjoc201206013
[1] Foroumadi, A.; Mansouri, S.; Kiani, Z.; Rahmani. A. Eur. J. Med. Chem. 2003, 38,851.
[2] Cheng, J.; Liu, F.; Song, B-A.;Yang, S.; Hu, D.-Y.; Jin, L.-H.; Chen, Z.; Xue, W. Chin. J. Org. Chem. 2008, 28, 894 (in Chinese). (陈江, 刘芳, 宋宝安, 杨松, 胡德禹, 金林红, 陈卓, 薛伟, 有机化学, 2008, 28, 894.)
[3] Dimmock, J. R.; Vashishtha, S. C.; Stables, J. P. Eur. J. Med. Chem. 2000, 35, 241.
[4] Telvekar,V. N.; Belubbi, A.; Bairwa, V. K.; Satardekar, K. Bioorg. Med. Chem. Lett. 2012, 22, 2343.
[5] Himmel, D. M.; Sarafianos, S. G.; Dharmasena, S.; Hossain, M. M.; Simandle, K. M.; Ilina, T.; Jr, A. C.; Knight, J. L.; Julias, J. G.; Clark, P. K.; Jespersen, K. K.; Levy, R. M.; Hughes, S. H.; Parniak, M. A.; Arnold, E. ACS Chem. Biol. 2006, 15, 702.
[6] Kalinowskl, D. A.; Richardson, E. D. Pharmacol. Rev. 2005, 57, 547.
[7] Lovejoy, D. B.; Richardson, D. R. Blood 2002, 100, 666.
[8] Richardson, D. R.; Kalinowski, D. S.; Lau, S.; Jansson, P. J.; Lovejoy, D. B. Biochim. Biophys. Acta, Gen Subj. 2009, 1790, 702.
[9] Kalinowski, D. S.; Yu, Y.; Sharpe, P. C.; Islam, M.; Liao, Y. T.; Lovejoy, D. B.; Kumar, N.; Bernhardt, P. V.; Richardson, D. R. J. Med. Chem. 2007, 50, 3716.
[10] Melnyk, P.; Leroux, V.; Sergheraerta, C.; Grellier, P. Bioorg. Med. Chem. Lett. 2006, 16, 31.
[11] Rollas, S.; Küçükgüzel, G. Molecules 2007, 12, 1910.
[12] Foroumadi, A.; Mansouri, S.; Kiani, Z.; Rahmani, A. Eur. J. Med. Chem. 2003, 38, 851.
[13] Thomasco, L. M.; Gadwood, R. C.; Weaver, E. A.; Ochoada, J. M.; Ford, C. W.; Zurenko, G. E.; Hamel, J. C.; Stapert, D.; Moerman, J. K.; Schaadt, R. D.; Yagi, B. H. Bioorg. Med. Chem. Lett. 2003, 13, 4193.
[14] Karakus. S.; Rollas, S. Farmaco 2002, 57, 577.
[15] Schenone, S.; Brullo, C.; Bruno, O.; Bondavalli, F.; Ranise, A.; Filippelli, W.; Rinaldi, B.; Capuanob, A.; Falcone, G. Bioorg. Med. Chem. 2006, 14, 1698
[16] Palaska, E.; Sahin, G.; Kelicen, P.; Durlu, N. T.; Altinok G. Farmaco 2002, 57, 101.
[17] Terzioglu, N.; Gürsoy, A. Eur. J. Med. Chem. 2003, 38, 781.
[18] Liu, Z.-C.; Liu, X.-X.; Wang, Y.-H.; Yang, L. Chin. J. Org. Chem. 2011, 31, 136 (in Chinese). (刘志昌, 刘晓霞, 王应红, 杨录, 有机化学, 2011, 31, 136.)
[19] Zhu, S.-S.; Lu, J.-R.; Xin, C.-W.; Lu, B.-W.; Bao, X.-R.; Tang, D.-W.; Zou, M.; Liu, Q. Chin. J. Org.Chem. 2010, 30, 1914 (in Chinese). (朱姗姗, 卢俊瑞, 辛春伟, 卢博为, 鲍秀荣, 唐大伟, 邹敏, 刘倩, 有机化学, 2010, 30, 1914.)
[20] Li, Y.-L. Clinical Microbiology and Inspection, People’s Health Press, Beijing, 1995, p. 77 (in Chinese). (李影林, 临床微生物学及检验, 人民卫生出版社, 北京, 1995, p. 77.)
/
〈 |
|
〉 |